Glomerular disease in 2014: advances in basic science and translational medicine
- PMID: 25584803
- DOI: 10.1038/nrneph.2014.248
Glomerular disease in 2014: advances in basic science and translational medicine
Abstract
Knowledge of the pathogenesis of glomerular disease and approaches to therapy continued to advance in 2014. Key studies identified thrombospondin type-1 domain-containing protein 7A as an antigenic target in primary membranous nephropathy, and demonstrated efficacy of rituximab as maintenance therapy in relapsing or steroid-dependent nephrotic syndrome and antineutrophil cytoplasmic antibody-associated vasculitis.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
